In 2000 Disc Dynamics secured $65 million to fund the development of DASCOR, a disc arthroplasty system.
Unable to obtain FDA approval to commence a pivotal study in the U.S., it seems DD has exhausted all possible funding and with its operating funds depleted, DD commenced a wind down of its business effective December 31st, 2009 and has terminated all of its employees and discontinued all financial support of clinical studies.
“Disc Dynamics RIP” http://ow.ly/11UDK
“The Blame Game” http://ow.ly/11UAg
“Disc Dynamics CEO resigns; firm may not seek replacement” http://ow.ly/11UKw